Competing Risks: A Practical Perspective

Competing Risks: A Practical Perspective

Volumn , Issue , 2007, Pages 1-224

  Pintilie, Melania ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84948775902     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470870709     Document Type: Book

References (63)

1. Aalen, O. (1978a). Nonparametric estimation of partial transition probabilities in multiple decrement models. Annals of Statistics, 6, 534-545.
2. Aalen, O. (1978b). Nonparametric inference for a family of counting processes. Annals of Statistics, 6, 701-726.
3. Allison, P. (1995) Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: BBU Press, SAS Institute.
4. Benichou, J. and Gail, M. H. (1990). Estimates of absolute cause-specific risk in cohort studies. Biometrics, 46, 813-826.
5. Bernoulli, D. (1760). Essai d'une nouvelle analyse de la mortalité causée par la petite vérole, et des avantages de l'inoculation pour la prévenir. Mémoir de l'Academie Royale de Science. 1-45.
6. Breslow, N. (1974). Covariance analysis of censored survival data. Biometrics, 30, 89-99.
7. Cantor, A. (2003) SAS Survival Analysis Techniques for Medical Research. Cary, NC: BBU Press, SAS Institute.
8. Caplan, R. J., Pajak, T. F. and Cox, J. D. (1994). Analysis of probability and risk of cause-specific failure. International Journal of Radiation Oncology, Biology, Physics, 29, 1183-1186.
9. Choudhury, J. B. (2002). Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Statistics in Medicine, 21, 1129-1144.
10. Collett, D. (2003) Modelling Survival Data in Medical Research. Boca Raton, FL: Chapman & Hall/CRC.
11. Couban, S., Simpson, D. R., Barnett, M. J., Bredeson, C., Hubesch, L., Kang, H. L., Shore, T. B., Walker, I. R., Browett, P., Messner, H. A., Panzarella, T. and Lipton, J. H. (2002). A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood, 100, 1525-531.
12. Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society, Series B, 34, 187-220.
13. Cox, D. R. and Oakes, D. (1984) Analysis of Survival Data. London:Chapman & Hall.
14. Crowder, M. (1996). Some tests based on extreme values for a parametric survival model. Journal of the Royal Statistical Society, Series B, 58, 417-424.
15. Crowder, M. (1997). A test for independence of competing risks with discrete failure times. Lifetime Data Analysis, 3, 215-223.
16. Crowder, M. (2001) Classical Competing Risks. Boca Raton, FL: Chapman & Hall/CRC.
17. David, H. A. and Moeschberger, M. L. (1978) The Theory of Competing Risks. London: Griffin.
18. Dewan, I., Deshpande, J. V. and Kulathinal, S. B. (2004). On testing dependence between time to failure and cause of failure via conditional probabilities. Scandinavian Journal of Statistics, 31, 79-91.
19. Dinse, G. E. and Larson, M. G. (1986). A note on semi-Markov models for partially censored data. Biometrika, 73, 379-386.
20. Efron, B. (1977). Efficiency of Cox's likelihood function for censored data. Journal of the American Statistical Association, 72, 557-565.
21. Feller, W. (1951). The asymptotic distribution of the range of sums of independent random variables. Annals of Mathematical Statistics, 22, 427-432.
22. Fine, J. P. (1999). Analysing competing risks data with transformation models. Journal of the Royal Statistical Society, Series B, 61, 817-830.
23. Fine, J. P. and Gray, R. J. (1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the Americal Statistical Association, 94, 496-509.
24. Fox, J. (2002) An R and S-PLUS Companion to Applied Regression. Thousand Oakes, CA: Sage.
25. Fyles, A., Milosevic, M., Hedley, D., Pintilie, M., Levin, W., Manchul, L. and Hill, R. P. (2002). Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. Journal of Clinical Oncology, 20, 680-687.
26. Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M. and Olivotto, I. A. (2004). Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. New England Journal of Medicine, 351, 963-970.
27. Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Straus, D. J., Clarkson, B. D. and Brennan, M. F. (1993). On the use of cause-specific failure and conditional failure probabilities - examples from clinical oncology data. Journal of the American Statistical Association, 88, 400-409.
28. Gelman, R., Gelber, R., Henderson, I. C., Coleman, C. N. and Harris, J. R. (1990). Improved methodology for analyzing local and distant recurrence. Journal of Clinical Oncology, 8, 548-555.
29. Gooley, T. A., Leisenring, W., Crowley, J. and Storer, B. E. (1999). Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695-706.
30. Graunt, J. (1662) Natural and political observations, mentioned in a following Index, and made upon the Bills of Mortality. London: Tho. Roycroft.
31. Gray, R. J. (1988). A class of k-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 16, 1141-1154.
32. Hall, W. J. and Wellner, J. A. (1980). Confidence bands for a survival curve from censored data. Biometrika, 67, 133-143.
33. Halley, E. (1693). An estimate of the degrees of the mortality of mankind, drawn from curious tables of the births and funerals at the city of Breslaw. Philosophical Transactions of the Royal Society of London, 17, 596-610.
34. Kalbfleisch, J. D. and Prentice, R. L. (1980) The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, Inc.
35. Kalbfleisch, J. D. and Prentice, R. L. (2002) The Statistical Analysis of Failure Time Data. Hoboken, NJ: John Wiley & Sons, Inc.
36. Kaplan, E. L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
37. Kochar, S. C., Lam, K. F. and Yip, P. S. F. (2002). Generalized supremum tests for the equality of cause specific hazard rates. Lifetime Data Analysis, 8, 277-288.
38. Korn, E. L. and Dorey, F. J. (1992). Applications of crude incidence curves. Statistics in Medicine, 11, 813-829.
39. Kulathinal, S. B. and Gasbarra, D. (2002). Testing equality of causespecific hazard rates corresponding to m competing risks among k groups. Lifetime Data Analysis, 8, 147-161.
40. Larson, M. G. and Dinse, G. E. (1985). A mixture model for the regression analysis of competing risks data. Applied Statistics, 34, 201-211.
41. Lawless, J. F. (1982) Statistical Models and Methods for Lifetime Data. New York: John Wiley & Sons, Inc.
42. Lin, D. Y. (1997). Non-parametric inference for cumulative incidence functions in competing risks studies. Statistics in Medicine, 16, 901-910.
43. Lin, D. Y., Robins, J. M. and Wei, L. J. (1996). Comparing two failure time distributions in the presence of dependent censoring. Biometrika, 83, 381-393.
44. Lunn, M. (1998). Applying k-sample tests to conditional probabilities for competing risks in a clinical trial. Biometrics, 54, 1662-1672.
45. Maller, R. A. and Zhou, X. (2002). Analysis of parametric models for competing risks. Statistica Sinica, 12, 725-750.
46. Marubini, E. and Valsecchi, M. (1995) Analysing Survival Data from Clinical Trials and Observational Studies. Chichester: John Wiley & Sons, Ltd.
47. Matthews, D. E. (1988). Likelihood-based confidence intervals for functions of many parameters. Biometrika. 75, 139-144.
48. Milosevic, M. F., Fyles, A. W., Wong, R., Pintilie, M., Kavanagh, M. C., Levin, W., Manchul, L. A., Keane, T. J. and Hill, R. P. (1998). Interstitial fluid pressure in cervical carcinoma: within tumor heterogeneity, and relation to oxygen tension. Cancer, 82, 2418-2426.
49. Milosevic, M., Fyles, A., Hedley, D., Pintilie, M., Levin, W., Manchul, L. and Hill, R. (2001). Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Research, 61, 6400-6405.
50. Nelson, W. (1972). Theory and applications of hazard plotting for censored failure data. Technometrics, 14, 945-965.
51. Pepe, M. S. (1991). Inference for events with dependent risks in multiple endpoint studies. Journal of the American Statistical Association, 86, 770-778.
52. Pepe, M. S. and Fleming, T. R. (1991) Weighted Kaplan-Meier statistics:Large sample and optimality considerations. Journal of the Royal Statistical Society, Series B, 53, 341-352.
53. Pepe, M. S. and Mori, M. (1993). Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statistics in Medicine, 12, 737-751.
54. Petersen, P., Tsang, R., Gospodarowicz, M., Pintilie, M., Wells, W., Hodgson, D., Sun, A. and Crump, M. (2004a). Stage I and II Hodgkin's disease: Long term outcome and second cancer risk. Radiotherapy and Oncology, 72, S23.
55. Petersen, P. M., Gospodarowicz, M., Tsang, R., Pintilie, M., Wells, W., Hodgson, D., Sun, A., Crump, M., Patterson, B. and Bailey, D. (2004b). Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. Journal of Clinical Oncology, 22, 563S.
56. Pintilie, M. (2002). Dealing with competing risks: testing covariates and calculating sample size. Statistics in Medicine, 21, 3317-3324.
57. Rowe, P. J., Boccard, S., Farley, T. M. M., Peregoudov, S., Reinprayoon, D., Koetsawang, S., Wu, S. C., Gopalan, S., Xiem, N. T., de la Concepción, O., Andolsek-Jeras, L., Sikazwe, N. C., Ramos, R. M., Dubnitskaya, L., Pizarro, E., Grimon, R. U., Cardet, E. C., Zhuang, L. Q., Fen, W. Y., Hao, W. Y., McCarthy, T., Nikanorova, S., Bartfai, G., Khodjaeva, R. K., Boukhris, M. M., Wu, X. R. and Aroustamian, K. (1997). Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C. Contraception. 56, 341-352.
58. Scrutinio, D., Cimminiello, C., Marubini, E., Pitzalis, M. V., Di Biase, M. and Rizzon, P. (2001). Ticlopidine versus aspirin after myocardial infarction (STAMI) trial. Journal of the American College of Cardiology, 37, 1259-1265.
59. Tai, B.-C., Peregoudov, A. and Machin, D. (2001). A competing risk approach to the analysis of trials of alternative intra-uterine devices (IUDs) for fertility regulation. Statistics in Medicine, 20, 3589-3600.
60. Tai, B.-C., White, I. R., Gebski, V. and Machin, D. (2002). On the issue of 'multiple' first failures in competing risks analysis. Statistics in Medicine, 21, 2243-2255.
61. Therneau, T. and Grambsch, P. (2000) Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag.
62. Tsiatis, A. (1975). A nonidentifiability aspect of the problem of competing risks. Proceedings of the National Academy of Sciences of the United States of America, 72, 20-22.
63. Wong, R. K. W., Fyles, A., Milosevic, M., Pintilie, M. and Hill, R. P. (1997). Heterogeneity of polarographic oxygen tension measurements in cervix cancer: An evaluation of within and between tumor variability, probe position, and track depth. International Journal of Radiation Oncology, Biology, Physics, 39, 405-412.